Molly White
Corporate Officer/Principal en DYNE THERAPEUTICS, INC. .
Perfil
Molly White is currently the Vice President-Strategic Initiatives at Dyne Therapeutics, Inc. She previously served as the Chief Executive Officer at Myotonic Dystrophy Foundation from 2012 to 2019.
Ms. White holds a graduate degree from the University of Iowa and an undergraduate degree from The University of Montana.
Cargos activos de Molly White
| Empresas | Cargo | Inicio |
|---|---|---|
| DYNE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2020 |
Antiguos cargos conocidos de Molly White.
| Empresas | Cargo | Fin |
|---|---|---|
Myotonic Dystrophy Foundation
 Myotonic Dystrophy Foundation Investment Trusts/Mutual FundsMiscellaneous The Myotonic Dystrophy Foundation is a non-profit organization that supports families living with myotonic dystrophy by providing comprehensive resources and driving research to accelerate the discovery of therapies. The non-profit company is based in San Francisco, CA. The foundation has invested over $10,000,000 and has served more than 10,000 people. The company's mission is to support and connect the myotonic dystrophy community, provide resources and advocate for care, and accelerate research toward treatments and a cure. | Director de Operaciones | 01/12/2019 |
Formación de Molly White.
| The University of Montana | Undergraduate Degree |
| University of Iowa | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| DYNE THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Myotonic Dystrophy Foundation
Myotonic Dystrophy Foundation Investment Trusts/Mutual FundsMiscellaneous The Myotonic Dystrophy Foundation is a non-profit organization that supports families living with myotonic dystrophy by providing comprehensive resources and driving research to accelerate the discovery of therapies. The non-profit company is based in San Francisco, CA. The foundation has invested over $10,000,000 and has served more than 10,000 people. The company's mission is to support and connect the myotonic dystrophy community, provide resources and advocate for care, and accelerate research toward treatments and a cure. | Miscellaneous |
- Bolsa de valores
- Insiders
- Molly White